{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-294837","form_type":"8-K","ticker":"ENTA","cik":"0001177648","company_name":"ENANTA PHARMACEUTICALS INC","filed_at":"2026-07-02T20:56:37+00:00","discovered_at":"2026-07-02T20:58:03.382096+00:00","generated_at":"2026-07-02T20:58:10.024807+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Enanta enters ATM equity agreement with Jefferies for up to $75M","bullets":["Open Market Sale Agreement with Jefferies LLC as sales agent for at-the-market offerings.","Enanta may sell up to $75M of common stock from time to time on Nasdaq.","Jefferies will receive a commission of up to 3.0% of gross sales price per share.","Enanta has no obligation to sell any shares under the agreement.","Prospectus supplement filed July 2, 2026; shelf registration effective February 20, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-294837","json":"https://secwatch.observer/filing/0001193125-26-294837.json","markdown":"https://secwatch.observer/filing/0001193125-26-294837.md","text":"https://secwatch.observer/filing/0001193125-26-294837.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1177648/000119312526294837/0001193125-26-294837-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1177648/000119312526294837/d123412d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-02T20:58:10.024807+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}